According to Merck's latest financial reports the company's current EPS (TTM) is HK$14.14. In 2022 the company made an earnings per share (EPS) of HK$44.48 an increase over its 2021 EPS that were of HK$40.10.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$14.25 | -67.97% |
2022 | HK$44.48 | 10.92% |
2021 | HK$40.10 | 84.68% |
2020 | HK$21.71 | -27.2% |
2019 | HK$29.82 | 63.44% |
2018 | HK$18.25 | 151.11% |
2017 | HK$7.27 | -54.58% |
2016 | HK$16.00 | 30.21% |
2015 | HK$12.29 | -61.99% |
2014 | HK$32.32 | 180.51% |
2013 | HK$11.52 | -31.82% |
2012 | HK$16.90 | 6.62% |
2011 | HK$15.85 | 626.78% |
2010 | HK$2.18 | -95.05% |
2009 | HK$44.06 | 56.36% |
2008 | HK$28.18 | -449.04% |
2007 | -HK$8.07 | -150.98% |
2006 | HK$15.84 | -3.32% |
2005 | HK$16.38 | -20.08% |
2004 | HK$20.49 | -10.81% |
2003 | HK$22.98 | -6.92% |
2002 | HK$24.68 | 0% |
2001 | HK$24.68 | 7.43% |
2000 | HK$22.98 | 17.93% |
1999 | HK$19.48 | 13.06% |
1998 | HK$17.23 | 15.63% |
1997 | HK$14.90 | 20% |
1996 | HK$12.42 |